These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 36560529)
1. Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel Nechooshtan R; Ehrlich S; Vitikainen M; Makovitzki A; Dor E; Marcus H; Hefetz I; Pitel S; Wiebe M; Huuskonen A; Cherry L; Lupu E; Sapir Y; Holtzman T; Aftalion M; Gur D; Tamir H; Yahalom-Ronen Y; Ramot Y; Kronfeld N; Zarling D; Vallerga A; Tchelet R; Nyska A; Saloheimo M; Emalfarb M; Ophir Y Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560529 [TBL] [Abstract][Full Text] [Related]
2. RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge. Wong TY; Russ BP; Lee KS; Miller OA; Kang J; Cooper M; Winters MT; Rodriguez-Aponte SA; Dalvie NC; Johnston RS; Rader NA; Wong ZY; Cyphert HA; Martinez I; Shaligram U; Batwal S; Lothe R; Chandrasekaran R; Nagar G; Rajurkar M; Rao H; Bevere JR; Barbier M; Love JC; Damron FH mSphere; 2022 Aug; 7(4):e0024322. PubMed ID: 35968964 [TBL] [Abstract][Full Text] [Related]
3. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection. Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290 [TBL] [Abstract][Full Text] [Related]
4. Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants. Bajoria S; Kaur K; Kumru OS; Van Slyke G; Doering J; Novak H; Rodriguez Aponte SA; Dalvie NC; Naranjo CA; Johnston RS; Silverman JM; Kleanthous H; Love JC; Mantis NJ; Joshi SB; Volkin DB Hum Vaccin Immunother; 2022 Nov; 18(5):2079346. PubMed ID: 35666264 [TBL] [Abstract][Full Text] [Related]
5. Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Ramot Y; Kronfeld N; Ophir Y; Ezov N; Friedman S; Saloheimo M; Vitikainen M; Ben-Artzi H; Avigdor A; Tchelet R; Valbuena Crespo N; Emalfarb M; Nyska A Toxicol Pathol; 2022 Apr; 50(3):294-307. PubMed ID: 35514116 [TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of immunogenicity, efficacy and safety of a recombinant plant-based SARS-CoV-2 RBD vaccine formulated with 3M-052-Alum adjuvant. Phoolcharoen W; Shanmugaraj B; Khorattanakulchai N; Sunyakumthorn P; Pichyangkul S; Taepavarapruk P; Praserthsee W; Malaivijitnond S; Manopwisedjaroen S; Thitithanyanont A; Srisutthisamphan K; Jongkaewwattana A; Tomai M; Fox CB; Taychakhoonavudh S Vaccine; 2023 Apr; 41(17):2781-2792. PubMed ID: 36963999 [TBL] [Abstract][Full Text] [Related]